Putting the squeeze on cells
25 January 2013
Living cells are surrounded by a membrane that tightly regulates what gets in and out of the cell. This barrier is necessary for cells to control their internal environment, but it makes it more difficult for scientists to deliver large molecules such as nanoparticles for imaging, or proteins that can reprogram them into pluripotent stem cells.
Researchers from MIT have now found a safe and efficient way to get large molecules through the cell membrane, by squeezing the cells through a narrow constriction that opens up tiny, temporary holes in the membrane. Any large molecules floating outside the cell - such as RNA, proteins or nanoparticles - can slide through the membrane during this disruption.
Using this technique, the researchers were able to deliver reprogramming proteins and generate induced pluripotent stem cells with a success rate 10 to 100 times better than any existing method. They also used it to deliver nanoparticles, including carbon nanotubes and quantum dots, which can be used to image cells and monitor what's happening inside them.
''It's very useful to be able to get large molecules into cells. We thought it might be interesting if you could have a relatively simple system that could deliver many different compounds,'' says Klavs Jensen, the Warren K. Lewis Professor of Chemical Engineering, professor of materials science and engineering, and a senior author of a paper describing the new device in this week's issue of the Proceedings of the National Academy of Sciences.
Robert Langer, the David H. Koch Institute Professor at MIT, is also a senior author of the paper. Lead authors are chemical engineering graduate student Armon Sharei, Koch Institute research scientist Janet Zoldan, and chemical engineering research associate Andrea Adamo.
A general approach
Biologists have previously developed several ways to get large molecules into cells, but all of them have drawbacks. DNA or RNA can be packaged into viruses, which are adept at entering cells, but that approach carries the risk that some of the viral DNA will get integrated into the host cell. This method is commonly used in lab experiments but has not been approved by the FDA for use in human patients.